KRATOM PARADISE · MIT Chewable TabletsCONCENTRATED MITRAGYNINE
150mg MIT Chewable Tablets
A pre-portioned kratom extract format in Mango and Pomberry. These MIT chewable tablets are labeled in milligrams of mitragynine per tablet and offered in six count options. Select the flavor first, then open the matching product-specific COA linked below.
If you prefer an unflavored concentrate sold by net weight, compare 90% MIT kratom extract powder. Do not treat tablet milligrams and a powder percentage as directly interchangeable label claims.
Concentrated mitragynine without a scale, mixing, or the mess of loose powder.
Choose Mango or Pomberry, then select 5, 10, 25, 50, 100, or 250 tablets. Each flavor has its own product-specific lab report and matching product photography.
- Mango: the current finished-tablet report lists 146 mg mitragynine per tablet.
- Pomberry: the current FESA report lists 158.85 mg mitragynine per 0.9712 g unit, with 7-hydroxymitragynine not detected and a passing residual-solvents panel.
Select a flavor to see its matching product photos. Both complete lab reports are linked on this page.
$13.99
Free U.S. shipping on qualifying orders $99+Shipping details & restrictions
Shipping, restrictions & returns
CONCENTRATED KRATOM
A FIRM CHEW.
NO LOOSE POWDER.
These MIT tablets are firm, dry chewables rather than soft gummies. Choose Mango for a familiar tropical-fruit profile or Pomberry for a brighter sweet-tart pomegranate-and-berry profile.
These tablets contain concentrated extract, not ground leaves. Mitragynine is one of kratom’s main active compounds. Kratom can produce stimulation and alertness as well as relaxation and sedation; the experience varies with the product, amount consumed and individual.
For a softer fruit chew, see our kratom gummies. They contain less mitragynine per piece than these tablets. The two are not interchangeable piece for piece.
FLAVOR-SPECIFIC REPORTS
Mango & Pomberry
- Mango mitragynine
- 146mg / tablet
- Pomberry mitragynine
- 158.85mg / unit
- Mango report
- Lot M/150/002
- Pomberry report
- FESA · August 19, 2026
The Mango and Pomberry results come from separate finished-tablet reports. Use the flavor-specific links on this page for the complete results and testing scope.
Keep the original package tightly closed and away from humidity, direct light, excess heat, children, and pets.
This product contains concentrated mitragynine. Risks include adverse effects, dependence, withdrawal, and interactions. Follow the current warning and seek qualified medical help for concerning symptoms.
BEFORE YOU BUY
YOUR QUESTIONS.
ANSWERED.
Is this a soft gummy?
No. Mango MIT Tablets are firm, dry chewables. If you prefer a soft, sweeter texture, see our kratom gummies.
Why does the report say 146mg rather than 150mg?
150mg is the product specification; lot M/150/002 lab tested at 146mg of mitragynine per tablet. The report does not explain that difference. We show the measured result alongside the specification so you can see both before buying.
What else is in the tablets?
For the full ingredient and allergen statement, ask us for the current package information before ordering. The potency report is not an ingredient list.
Can I substitute one tablet for one kratom capsule?
No. These tablets contain concentrated mitragynine. Our leaf capsules contain ground kratom leaves, not the same amount of active compound. The products are not interchangeable by count.
RELATED PRODUCTS
More from this product family.
